An update of phase 2 trial results: Patients with recurrent malignant glioma treated with iodine 131-labeled murine antitenascin monoclonal antibody 81C6 into the resection cavity

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Reardon, D; Akabani, G; Friedman, A; Friedman, H; McLendon, R; Quinn, J; Rich, J; Vredenburgh, J; Zalutsky, M; Bigner, D

Published Date

  • July 1, 2005

Published In

Volume / Issue

  • 7 / 3

Start / End Page

  • 311 - 311

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 1522-8517

Conference Name

  • 2nd Quadrennial Meeting of the World-Federation-of-Neuro-Oncology/6th Meeting of the European-Association-for-Neur-Oncology

Conference Location

  • Edinburgh, SCOTLAND

Conference Start Date

  • May 5, 2005

Conference End Date

  • May 8, 2005